Suppr超能文献

颞骨板障内扩张性血管病变:法布里病听力损失的另一致病因素?

Temporal intradiploic dilative vasculopathy: an additional pathogenic factor for the hearing loss in fabry disease?

作者信息

Moura Carla Pinto, Soares Carlos, Seixas Daniela, Ayres-Bastos Margarida, Oliveira João Paulo

机构信息

Department of Otolaryngology, Faculty of Medicine, University of Porto and Hospital São João, Alameda Hernâni Monteiro, 4200-319, Porto, Portugal,

出版信息

JIMD Rep. 2013;7:7-12. doi: 10.1007/8904_2012_132. Epub 2012 Mar 24.

Abstract

Fabry disease (FD) is caused by progressive accumulation of neutral glycosphingolipids, including in ganglion neural and vascular endothelial cells, as a result of lysosomal α-galactosidase deficiency. High frequencies progressive sensorineural hearing loss (HL), sudden deafness, tinnitus and dizziness are otological symptoms frequently reported.A 45-year-old man with FD, on haemodialysis since age 25, complaining of progressive HL, was started on enzyme replacement therapy (ERT) because of cardiac complications. A bilateral sloping sensorineural HL was found at baseline audiological evaluation. Computed tomography of the ears showed enlargement of the intradiploic vascular channels, principally in the petrous bone. The magnetic resonance angiography showed elongation and ectasia of the middle cerebral arteries and the arteries of the Circle of Willis, particularly the internal carotid and the basilar arteries. Follow-up audiological evaluations documented progressive worsening of HL, mainly in the high frequencies range, despite high dose ERT and evidence of cardiac improvement.The intradiploic vascular abnormalities of the temporal bones reported herein have never been described in association with FD and may have contributed to the pathogenesis of progressive HL, by a 'stealing' effect upon the cochlear blood supply (like in cavernous haemangioma of the internal auditory meatus), in addition to the other mechanisms of ischaemic injury to the Organ of Corti described in FD. This clinical observation shows the value of comprehensive neuroimaging investigation of HL in FD and emphasizes the importance of early institution of specific therapy, before the occurrence of irreversible inner ear lesions and hearing damage.

摘要

法布里病(FD)是由于溶酶体α-半乳糖苷酶缺乏,导致中性糖鞘脂在神经节神经细胞和血管内皮细胞等中进行性蓄积所致。高频进行性感音神经性听力损失(HL)、突发性耳聋、耳鸣和头晕是FD患者经常报告的耳科症状。一名45岁的FD男性患者,自25岁起开始接受血液透析,因出现心脏并发症而开始接受酶替代疗法(ERT),该患者抱怨患有进行性HL。在基线听力评估中发现双侧斜坡形感音神经性HL。耳部计算机断层扫描显示板障内血管通道增宽,主要位于岩骨。磁共振血管造影显示大脑中动脉和Willis环的动脉,尤其是颈内动脉和基底动脉伸长和扩张。随访听力评估记录显示,尽管进行了高剂量ERT且心脏状况有所改善,但HL仍主要在高频范围内进行性恶化。本文报道的颞骨板障内血管异常从未被描述与FD相关,除了FD中描述的对柯蒂氏器的其他缺血性损伤机制外,可能通过对耳蜗血供的“窃取”效应(如内耳道海绵状血管瘤)导致进行性HL的发病机制。这一临床观察表明了对FD患者HL进行全面神经影像学检查的价值,并强调了在不可逆内耳病变和听力损害发生之前尽早开始特异性治疗的重要性。

相似文献

3
Auditory and vestibular findings in Fabry disease: a study of hemizygous males and heterozygous females.
Acta Paediatr Suppl. 2003 Dec;92(443):33-7; discussion 27. doi: 10.1111/j.1651-2227.2003.tb00219.x.
4
Hearing loss in adult patients with Fabry disease treated with enzyme replacement therapy.
J Inherit Metab Dis. 2015 Mar;38(2):351-8. doi: 10.1007/s10545-014-9783-7. Epub 2014 Nov 14.
6
Anderson-Fabry disease: a multiorgan disease.
Curr Pharm Des. 2013;19(33):5974-96. doi: 10.2174/13816128113199990352.
8
Cardiac and renal dysfunction is associated with progressive hearing loss in patients with Fabry disease.
PLoS One. 2017 Nov 21;12(11):e0188103. doi: 10.1371/journal.pone.0188103. eCollection 2017.
9
Hearing loss in children with Fabry disease.
J Inherit Metab Dis. 2017 Sep;40(5):725-731. doi: 10.1007/s10545-017-0051-5. Epub 2017 May 31.
10
Neuropathic and cerebrovascular correlates of hearing loss in Fabry disease.
Brain. 2007 Jan;130(Pt 1):143-50. doi: 10.1093/brain/awl310. Epub 2006 Nov 14.

引用本文的文献

本文引用的文献

2
Intracranial dilative arteriopathy is associated with chronic kidney disease and small vessel diseases in the elderly.
J Stroke Cerebrovasc Dis. 2009 Nov-Dec;18(6):435-42. doi: 10.1016/j.jstrokecerebrovasdis.2009.01.011.
3
Ear symptoms in children with Fabry disease: data from the Fabry Outcome Survey.
J Inherit Metab Dis. 2009 Dec;32(6):739. doi: 10.1007/s10545-009-1290-x. Epub 2009 Oct 27.
4
Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry.
Mol Genet Metab. 2008 Feb;93(2):112-28. doi: 10.1016/j.ymgme.2007.09.013. Epub 2007 Nov 26.
5
Vestibular and auditory deficits in Fabry disease and their response to enzyme replacement therapy.
J Neurol. 2007 Oct;254(10):1433-42. doi: 10.1007/s00415-007-0575-y. Epub 2007 Oct 15.
7
Neuropathic and cerebrovascular correlates of hearing loss in Fabry disease.
Brain. 2007 Jan;130(Pt 1):143-50. doi: 10.1093/brain/awl310. Epub 2006 Nov 14.
8
Hearing loss in Fabry disease: data from the Fabry Outcome Survey.
Eur J Clin Invest. 2006 Sep;36(9):654-62. doi: 10.1111/j.1365-2362.2006.01702.x.
9
CNS manifestations of Fabry's disease.
Lancet Neurol. 2006 Sep;5(9):791-5. doi: 10.1016/S1474-4422(06)70548-8.
10
Intracranial arterial dolichoectasia and small-vessel disease in stroke patients.
Ann Neurol. 2005 Apr;57(4):472-9. doi: 10.1002/ana.20423.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验